chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Injection site pain, Pollakiuria, Pyrexia
Clinical narrative: sore arm of shot the next day, slight fever the next day, fatigue the next day, frequent urination the night of vaccine (once every hour); sore arm of shot the next day, slight fever the next day, fatigue the next day, frequent urination the night of vaccine (once every hour); sore arm of shot the next day, slight fever the next day, fatigue the next day, frequent urination the night of vaccine (once every hour); frequent urination the night of vaccine (once every hour); This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 61-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Ew0167), via an unspecified route of administration, administered in Arm Left on 28May2021 at 17:00 (age at the time of vaccination was 61 years) as DOSE 2, SINGLE for covid-19 immunisation at pharmacy or drug Store. The patient medical history was not reported. Concomitant medication(s) and any other medications the patient received within 2 weeks of vaccination included Ibuprofen; Acetylsalicylic acid (ASPRIN); Diphenhydramine hydrochloride (BENADRYL) and Fish oil, all taken for an unspecified indication, start and stop date were not reported. Historically, the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number Ew0171), via an unspecified route of administration, administered in Left Arm on 30Apr2021 at 18:00 (age at the time of vaccination was 61 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29May2021 at 12:00 AM, the patient experienced sore arm of shot the next day, slight fever the next day and fatigue the next day. On 29May2021, the patient experienced frequent urination the night of vaccine (once every hour). Reportedly the events were sore arm of shot, slight fever and fatigue all the next day along with frequent urination the night of vaccine (once every hour). No treatment was received to treat events. Since the vaccination, the patient has not been tested for COVID-19. The case was reported as non-serious. The outcome of all the events was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Nocturia, Pain in extremity, Pyrexia
Clinical narrative: sore arm of shot the next day, slight fever the next day, fatigue the next day, frequent urination the night of vaccine (once every hour); sore arm of shot the next day, slight fever the next day, fatigue the next day, frequent urination the night of vaccine (once every hour); sore arm of shot the next day, slight fever the next day, fatigue the next day, frequent urination the night of vaccine (once every hour); frequent urination the night of vaccine (once every hour); This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 61-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Ew0167), via an unspecified route of administration, administered in Arm Left on 28May2021 at 17:00 (age at the time of vaccination was 61 years) as DOSE 2, SINGLE for covid-19 immunisation at pharmacy or drug Store. The patient medical history was not reported. Concomitant medication(s) and any other medications the patient received within 2 weeks of vaccination included Ibuprofen; Acetylsalicylic acid (ASPRIN); Diphenhydramine hydrochloride (BENADRYL) and Fish oil, all taken for an unspecified indication, start and stop date were not reported. Historically, the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number Ew0171), via an unspecified route of administration, administered in Left Arm on 30Apr2021 at 18:00 (age at the time of vaccination was 61 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29May2021 at 12:00 AM, the patient experienced sore arm of shot the next day, slight fever the next day and fatigue the next day. On 29May2021, the patient experienced frequent urination the night of vaccine (once every hour). Reportedly the events were sore arm of shot, slight fever and fatigue all the next day along with frequent urination the night of vaccine (once every hour). No treatment was received to treat events. Since the vaccination, the patient has not been tested for COVID-19. The case was reported as non-serious. The outcome of all the events was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Culture throat negative, Headache, Malaise, Oropharyngeal pain
Clinical narrative: diffuse headache; sore throat; chills; low-grade fever; malaise; This is a spontaneous report from a contactable Physician. A 12-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0186), DOSE 1 intramuscular, administered in Right Arm on 18May2021 15:00 (Age at Vaccination 12-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included rhinitis allergic, grass pollen (environmental) with anaphylactic reaction from an unknown date and unknown if ongoing. Concomitant medications were not reported. Patient receive did not any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Adverse event result in any of the following Doctor or other healthcare professional office/clinic visit. Prior to vaccination, patient did not was the patient diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19. Device Date: 01Jun2021. On 24May2021 15:00 The patient experienced, diffuse headache, sore throat, chills, low-grade fever, and malaise. Lasted 4 days. The patient underwent lab tests and procedures which included polymerase chain reaction Nasal Swab on 26May2021.The outcome of all the events was recovered on May2021.   Follow-Up (30Jun2021): Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: diffuse headache; sore throat; chills; low-grade fever; malaise; This is a spontaneous report from a contactable Physician. A 12-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0186), DOSE 1 intramuscular, administered in Right Arm on 18May2021 15:00 (Age at Vaccination 12-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included rhinitis allergic, grass pollen (environmental) with anaphylactic reaction from an unknown date and unknown if ongoing. Concomitant medications were not reported. Patient receive did not any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Adverse event result in any of the following Doctor or other healthcare professional office/clinic visit. Prior to vaccination, patient did not was the patient diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19. Device Date: 01Jun2021. On 24May2021 15:00 The patient experienced, diffuse headache, sore throat, chills, low-grade fever, and malaise. Lasted 4 days. The patient underwent lab tests and procedures which included polymerase chain reaction Nasal Swab on 26May2021.The outcome of all the events was recovered on May2021.   Follow-Up (30Jun2021): Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Malaise, Oropharyngeal pain, Polymerase chain reaction
Clinical narrative: diffuse headache; sore throat; chills; low-grade fever; malaise; This is a spontaneous report from a contactable Physician. A 12-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0186), DOSE 1 intramuscular, administered in Right Arm on 18May2021 15:00 (Age at Vaccination 12-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included rhinitis allergic, grass pollen (environmental) with anaphylactic reaction from an unknown date and unknown if ongoing. Concomitant medications were not reported. Patient receive did not any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Adverse event result in any of the following Doctor or other healthcare professional office/clinic visit. Prior to vaccination, patient did not was the patient diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19. Device Date: 01Jun2021. On 24May2021 15:00 The patient experienced, diffuse headache, sore throat, chills, low-grade fever, and malaise. Lasted 4 days. The patient underwent lab tests and procedures which included polymerase chain reaction Nasal Swab on 26May2021.The outcome of all the events was recovered on May2021.   Follow-Up (30Jun2021): Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: diffuse headache; sore throat; chills; low-grade fever; malaise; This is a spontaneous report from a contactable Physician. A 12-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0186), DOSE 1 intramuscular, administered in Right Arm on 18May2021 15:00 (Age at Vaccination 12-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included rhinitis allergic, grass pollen (environmental) with anaphylactic reaction from an unknown date and unknown if ongoing. Concomitant medications were not reported. Patient receive did not any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Adverse event result in any of the following Doctor or other healthcare professional office/clinic visit. Prior to vaccination, patient did not was the patient diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19. Device Date: 01Jun2021. On 24May2021 15:00 The patient experienced, diffuse headache, sore throat, chills, low-grade fever, and malaise. Lasted 4 days. The patient underwent lab tests and procedures which included polymerase chain reaction Nasal Swab on 26May2021.The outcome of all the events was recovered on May2021.   Follow-Up (30Jun2021): Follow-up attempts are completed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood test, Computerised tomogram, Crying, Ear discomfort
Clinical narrative: it has moved from left to right wrist as of this past Sunday (10 days later) and has progressively gotten worse in both joints/describes it as pain she has never had before, on a scale of 10 it is 10; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; slight edema on both wrists and at the inoculation area as well; She is going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well; This is a spontaneous report from a contactable consumer (patient). A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 06May2021 (at the age of 53-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient reported that she received the 1st dose on 06May 2021, 6 days after (12May2021), she experienced extreme swelling in left hand and pain in left arm and wrist, which she reported yesterday (17May2021). Today (18May2021), she reported that it had moved from left to right wrist as of that past Sunday (10 days later, 16May2021) and had progressively gotten worse in both joints. She described it as pain she had never had before, on a scale of 10 it is 10. She was going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well. The clinical outcome for the events was not recovered.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Feeling hot, Joint swelling, Myalgia, Pain in extremity
Clinical narrative: it has moved from left to right wrist as of this past Sunday (10 days later) and has progressively gotten worse in both joints/describes it as pain she has never had before, on a scale of 10 it is 10; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; slight edema on both wrists and at the inoculation area as well; She is going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well; This is a spontaneous report from a contactable consumer (patient). A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 06May2021 (at the age of 53-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient reported that she received the 1st dose on 06May 2021, 6 days after (12May2021), she experienced extreme swelling in left hand and pain in left arm and wrist, which she reported yesterday (17May2021). Today (18May2021), she reported that it had moved from left to right wrist as of that past Sunday (10 days later, 16May2021) and had progressively gotten worse in both joints. She described it as pain she had never had before, on a scale of 10 it is 10. She was going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well. The clinical outcome for the events was not recovered.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, SARS-CoV-2 test, Transferrin saturation, Ultrasound testes, Vaccination site oedema
Clinical narrative: it has moved from left to right wrist as of this past Sunday (10 days later) and has progressively gotten worse in both joints/describes it as pain she has never had before, on a scale of 10 it is 10; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; slight edema on both wrists and at the inoculation area as well; She is going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well; This is a spontaneous report from a contactable consumer (patient). A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 06May2021 (at the age of 53-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient reported that she received the 1st dose on 06May 2021, 6 days after (12May2021), she experienced extreme swelling in left hand and pain in left arm and wrist, which she reported yesterday (17May2021). Today (18May2021), she reported that it had moved from left to right wrist as of that past Sunday (10 days later, 16May2021) and had progressively gotten worse in both joints. She described it as pain she had never had before, on a scale of 10 it is 10. She was going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well. The clinical outcome for the events was not recovered.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site swelling, Vitreous floaters
Clinical narrative: it has moved from left to right wrist as of this past Sunday (10 days later) and has progressively gotten worse in both joints/describes it as pain she has never had before, on a scale of 10 it is 10; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; slight edema on both wrists and at the inoculation area as well; She is going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well; This is a spontaneous report from a contactable consumer (patient). A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 06May2021 (at the age of 53-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient reported that she received the 1st dose on 06May 2021, 6 days after (12May2021), she experienced extreme swelling in left hand and pain in left arm and wrist, which she reported yesterday (17May2021). Today (18May2021), she reported that it had moved from left to right wrist as of that past Sunday (10 days later, 16May2021) and had progressively gotten worse in both joints. She described it as pain she had never had before, on a scale of 10 it is 10. She was going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well. The clinical outcome for the events was not recovered.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Oedema, Pain in extremity, Peripheral swelling, Vaccination site oedema
Clinical narrative: it has moved from left to right wrist as of this past Sunday (10 days later) and has progressively gotten worse in both joints/describes it as pain she has never had before, on a scale of 10 it is 10; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; she experienced extreme swelling in left hand and pain in left arm and wrist; slight edema on both wrists and at the inoculation area as well; She is going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well; This is a spontaneous report from a contactable consumer (patient). A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 06May2021 (at the age of 53-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient reported that she received the 1st dose on 06May 2021, 6 days after (12May2021), she experienced extreme swelling in left hand and pain in left arm and wrist, which she reported yesterday (17May2021). Today (18May2021), she reported that it had moved from left to right wrist as of that past Sunday (10 days later, 16May2021) and had progressively gotten worse in both joints. She described it as pain she had never had before, on a scale of 10 it is 10. She was going into the 3rd day of the initial joint pain, slight edema on both wrists and at the inoculation area as well. The clinical outcome for the events was not recovered.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Confusional state, Dizziness, Headache, Injection site erythema
Clinical narrative: Severe dizziness; Tightness in chest; Nausea; Increased headache; Confusion; Large raised swollen and red at injection site on left deltoid; Large raised swollen and red at injection site on left deltoid; Developed high fever 102.6F; This is a spontaneous report from a contactable other hcp. A 46-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EP6955), dose 1 via an unspecified route of administration, administered in Arm Left on 24May2021 15:30 as dose 1, single for covid-19 immunisation (at the age of 46-year-old). Medical history included covid-19 from an unknown date and unknown if ongoing. Concomitant medications included ergocalciferol (VIT D), ascorbic acid (VIT C), acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE), Vit B taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25May2021 22:45 PM patient experienced developed high fever 102.6F, Severe dizziness, tightness in chest, nausea, increased headache, confusion. Large raised swollen and red at injection site on left deltoid. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered with lasting effects.  Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site swelling, Nausea, Pyrexia
Clinical narrative: Severe dizziness; Tightness in chest; Nausea; Increased headache; Confusion; Large raised swollen and red at injection site on left deltoid; Large raised swollen and red at injection site on left deltoid; Developed high fever 102.6F; This is a spontaneous report from a contactable other hcp. A 46-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EP6955), dose 1 via an unspecified route of administration, administered in Arm Left on 24May2021 15:30 as dose 1, single for covid-19 immunisation (at the age of 46-year-old). Medical history included covid-19 from an unknown date and unknown if ongoing. Concomitant medications included ergocalciferol (VIT D), ascorbic acid (VIT C), acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE), Vit B taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25May2021 22:45 PM patient experienced developed high fever 102.6F, Severe dizziness, tightness in chest, nausea, increased headache, confusion. Large raised swollen and red at injection site on left deltoid. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered with lasting effects.  Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chest discomfort, Confusional state, Dizziness, Headache
Clinical narrative: Severe dizziness; Tightness in chest; Nausea; Increased headache; Confusion; Large raised swollen and red at injection site on left deltoid; Large raised swollen and red at injection site on left deltoid; Developed high fever 102.6F; This is a spontaneous report from a contactable other hcp. A 46-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EP6955), dose 1 via an unspecified route of administration, administered in Arm Left on 24May2021 15:30 as dose 1, single for covid-19 immunisation (at the age of 46-year-old). Medical history included covid-19 from an unknown date and unknown if ongoing. Concomitant medications included ergocalciferol (VIT D), ascorbic acid (VIT C), acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE), Vit B taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25May2021 22:45 PM patient experienced developed high fever 102.6F, Severe dizziness, tightness in chest, nausea, increased headache, confusion. Large raised swollen and red at injection site on left deltoid. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered with lasting effects.  Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Severe dizziness; Tightness in chest; Nausea; Increased headache; Confusion; Large raised swollen and red at injection site on left deltoid; Large raised swollen and red at injection site on left deltoid; Developed high fever 102.6F; This is a spontaneous report from a contactable other hcp. A 46-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EP6955), dose 1 via an unspecified route of administration, administered in Arm Left on 24May2021 15:30 as dose 1, single for covid-19 immunisation (at the age of 46-year-old). Medical history included covid-19 from an unknown date and unknown if ongoing. Concomitant medications included ergocalciferol (VIT D), ascorbic acid (VIT C), acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE), Vit B taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25May2021 22:45 PM patient experienced developed high fever 102.6F, Severe dizziness, tightness in chest, nausea, increased headache, confusion. Large raised swollen and red at injection site on left deltoid. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered with lasting effects.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Rash all down arm that the shot was given in. The rash has now gone into the other arm and below both arm pits.; Itching occurring on both legs; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 38-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: not reported/Lot Number: EW0175), via an unspecified route of administration, administered in arm right on 18May2021 (Age at vaccination 38-years-old), as dose 1, single for covid-19 immunization. The patient medical history included seasonal allergies. Patient received steroid shot for seasonal allergies within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination patient was not diagnosed with Covid. Since the vaccination patient has not been tested for COVID-19. On 24May2021, the patient experienced rash all down arm that the shot was given in. The rash has now gone into the other arm and below both arm pits, itching occurring on both legs. Timeframe between vaccination and starting of symptoms was 6 days. Therapeutic measures were not taken as a result of the events. Clinical outcome of the events was unknown.   Information on Lot/Batch number was available. Additional information has been requested.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Vertigo
Clinical narrative: Extreme vertigo; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 09:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 24Mar2021 at 08:30 as a single dose for COVID-19 immunisation. On 22Apr2021 at 09:00, the patient experienced extreme vertigo 24 hours after dose, which still existed 4 days after. It was reported that she never experienced anything like that in his life. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported adverse events. The clinical outcome of the event extreme vertigo was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: Extreme vertigo; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 09:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 24Mar2021 at 08:30 as a single dose for COVID-19 immunisation. On 22Apr2021 at 09:00, the patient experienced extreme vertigo 24 hours after dose, which still existed 4 days after. It was reported that she never experienced anything like that in his life. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported adverse events. The clinical outcome of the event extreme vertigo was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Burning sensation, Chills, Ear pain, Herpes zoster
Clinical narrative: Also on the right anterior neck area; Ear pain; Developed right neck and scalp rash; Burning; Swelling; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp; Also developed injection site pain; Fever; Chills; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Patient). A 33-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 01Jun2021 at 15:15 (Age at vaccination: 33 years) as dose 2, single for covid-19 immunisation. Medical history included psoriasis from an unknown date and unknown if ongoing and known allergies were reported as none. The patient concomitant medications were not reported. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 11May2021 at 15:15 as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Patient received vaccine facility type in hospital. On 02Jun2021 at 01:30, the patient experienced about 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias, also developed injection site pain, fever, chills. On 04Jun2021, developed right neck and scalp rash, burning, swelling. On 04Jun2021 at 01:30, the patient experienced also on the right anterior neck area, ear pain. No facial involvement. Patient visited doctor or other healthcare professional office/clinic visit. Treatment was received for the events as Valacyclovir (VALTREX) 1g oral tablet. The outcome of the events was reported as not recovered.   Follow-Up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Pain of skin, Pyrexia, Rash, Swelling
Clinical narrative: Also on the right anterior neck area; Ear pain; Developed right neck and scalp rash; Burning; Swelling; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp; Also developed injection site pain; Fever; Chills; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Patient). A 33-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 01Jun2021 at 15:15 (Age at vaccination: 33 years) as dose 2, single for covid-19 immunisation. Medical history included psoriasis from an unknown date and unknown if ongoing and known allergies were reported as none. The patient concomitant medications were not reported. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 11May2021 at 15:15 as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Patient received vaccine facility type in hospital. On 02Jun2021 at 01:30, the patient experienced about 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias, also developed injection site pain, fever, chills. On 04Jun2021, developed right neck and scalp rash, burning, swelling. On 04Jun2021 at 01:30, the patient experienced also on the right anterior neck area, ear pain. No facial involvement. Patient visited doctor or other healthcare professional office/clinic visit. Treatment was received for the events as Valacyclovir (VALTREX) 1g oral tablet. The outcome of the events was reported as not recovered.   Follow-Up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Burning sensation, Chills, Ear pain, Neck pain
Clinical narrative: Also on the right anterior neck area; Ear pain; Developed right neck and scalp rash; Burning; Swelling; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp; Also developed injection site pain; Fever; Chills; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Patient). A 33-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 01Jun2021 at 15:15 (Age at vaccination: 33 years) as dose 2, single for covid-19 immunisation. Medical history included psoriasis from an unknown date and unknown if ongoing and known allergies were reported as none. The patient concomitant medications were not reported. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 11May2021 at 15:15 as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Patient received vaccine facility type in hospital. On 02Jun2021 at 01:30, the patient experienced about 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias, also developed injection site pain, fever, chills. On 04Jun2021, developed right neck and scalp rash, burning, swelling. On 04Jun2021 at 01:30, the patient experienced also on the right anterior neck area, ear pain. No facial involvement. Patient visited doctor or other healthcare professional office/clinic visit. Treatment was received for the events as Valacyclovir (VALTREX) 1g oral tablet. The outcome of the events was reported as not recovered.   Follow-Up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain of skin, Pyrexia, Rash, Swelling, Vaccination site pain
Clinical narrative: Also on the right anterior neck area; Ear pain; Developed right neck and scalp rash; Burning; Swelling; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp; Also developed injection site pain; Fever; Chills; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Patient). A 33-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 01Jun2021 at 15:15 (Age at vaccination: 33 years) as dose 2, single for covid-19 immunisation. Medical history included psoriasis from an unknown date and unknown if ongoing and known allergies were reported as none. The patient concomitant medications were not reported. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 11May2021 at 15:15 as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Patient received vaccine facility type in hospital. On 02Jun2021 at 01:30, the patient experienced about 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias, also developed injection site pain, fever, chills. On 04Jun2021, developed right neck and scalp rash, burning, swelling. On 04Jun2021 at 01:30, the patient experienced also on the right anterior neck area, ear pain. No facial involvement. Patient visited doctor or other healthcare professional office/clinic visit. Treatment was received for the events as Valacyclovir (VALTREX) 1g oral tablet. The outcome of the events was reported as not recovered.   Follow-Up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Cardiac function test, Chest pain, Electrocardiogram, Fibrin D dimer
Clinical narrative: Chest pain; left arm pain; left hand numbness; back pain; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient).  A 36-years-old non-pregnant female patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no: not reported/Lot number: EW0178) via unspecified route of administration administered in arm left on 22May2021 02:00 PM (at the age of 36-years-old) as dose 1, single for covid-19 immunization at Pharmacy or Drug Store. Medical history and concomitant medications were none. Known allergies were reported as no. No covid prior vaccination and not tested for covid post vaccination. No other vaccines taken within four weeks and no other medications in two weeks. On 24May2021 12:00 AM, patient experienced with chest pain, left arm pain, back pain, left hand numbness. No relief since more than 2 weeks. AE resulted in Emergency room/department or urgent care, which causes patient went to Emergency in (hospital name) for 8 hrs. On an unspecified date, patient underwent lab tests and procedures which included Blood test, X-ray and cardiac scan with unknown results all. No relief in symptoms. No treatment AE received for the events caused. Outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Hypoaesthesia, Metabolic function test, Pain in extremity, Peripheral coldness
Clinical narrative: Chest pain; left arm pain; left hand numbness; back pain; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient).  A 36-years-old non-pregnant female patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no: not reported/Lot number: EW0178) via unspecified route of administration administered in arm left on 22May2021 02:00 PM (at the age of 36-years-old) as dose 1, single for covid-19 immunization at Pharmacy or Drug Store. Medical history and concomitant medications were none. Known allergies were reported as no. No covid prior vaccination and not tested for covid post vaccination. No other vaccines taken within four weeks and no other medications in two weeks. On 24May2021 12:00 AM, patient experienced with chest pain, left arm pain, back pain, left hand numbness. No relief since more than 2 weeks. AE resulted in Emergency room/department or urgent care, which causes patient went to Emergency in (hospital name) for 8 hrs. On an unspecified date, patient underwent lab tests and procedures which included Blood test, X-ray and cardiac scan with unknown results all. No relief in symptoms. No treatment AE received for the events caused. Outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: X-ray
Clinical narrative: Chest pain; left arm pain; left hand numbness; back pain; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient).  A 36-years-old non-pregnant female patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no: not reported/Lot number: EW0178) via unspecified route of administration administered in arm left on 22May2021 02:00 PM (at the age of 36-years-old) as dose 1, single for covid-19 immunization at Pharmacy or Drug Store. Medical history and concomitant medications were none. Known allergies were reported as no. No covid prior vaccination and not tested for covid post vaccination. No other vaccines taken within four weeks and no other medications in two weeks. On 24May2021 12:00 AM, patient experienced with chest pain, left arm pain, back pain, left hand numbness. No relief since more than 2 weeks. AE resulted in Emergency room/department or urgent care, which causes patient went to Emergency in (hospital name) for 8 hrs. On an unspecified date, patient underwent lab tests and procedures which included Blood test, X-ray and cardiac scan with unknown results all. No relief in symptoms. No treatment AE received for the events caused. Outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, Chest pain, Hypoaesthesia, Pain in extremity
Clinical narrative: Chest pain; left arm pain; left hand numbness; back pain; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient).  A 36-years-old non-pregnant female patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no: not reported/Lot number: EW0178) via unspecified route of administration administered in arm left on 22May2021 02:00 PM (at the age of 36-years-old) as dose 1, single for covid-19 immunization at Pharmacy or Drug Store. Medical history and concomitant medications were none. Known allergies were reported as no. No covid prior vaccination and not tested for covid post vaccination. No other vaccines taken within four weeks and no other medications in two weeks. On 24May2021 12:00 AM, patient experienced with chest pain, left arm pain, back pain, left hand numbness. No relief since more than 2 weeks. AE resulted in Emergency room/department or urgent care, which causes patient went to Emergency in (hospital name) for 8 hrs. On an unspecified date, patient underwent lab tests and procedures which included Blood test, X-ray and cardiac scan with unknown results all. No relief in symptoms. No treatment AE received for the events caused. Outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.